financetom
Business
financetom
/
Business
/
Nebius Prices $1 Billion Share Offering, Upsized $2.75 Billion Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nebius Prices $1 Billion Share Offering, Upsized $2.75 Billion Notes Offering
Sep 11, 2025 12:59 AM

03:38 AM EDT, 09/11/2025 (MT Newswires) -- Nebius Group ( NBIS ) said Thursday it priced a $1 billion public offering of class A shares at $92.50 apiece.

The company has granted underwriters a 30-day option to purchase up to an additional $150 million of shares. The offering is expected to close on Sept. 15.

Nebius ( NBIS ) expects net proceeds of about $979.5 million from the offering, or roughly $1.13 billion if the underwriters take up the option to purchase additional class in full.

Additionally, the company priced an upsized offering of $2.75 billion of convertible senior notes in two series, including roughly $1.38 billion of 1% notes due 2030 and about $1.38 billion of 2.75% notes due 2032.

Nebius ( NBIS ) granted initial purchasers of the notes a 13-day option to buy up to an additional $206.3 million each of the 2030 and 2032 notes.

The company aims to use the proceeds from the share and notes offerings to fund business growth, including the expansion of its data center presence, and for general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Jan 14, 2025
11:59 AM EST, 01/14/2025 (MT Newswires) -- UnitedHealth Group's ( UNH ) OptumRx, CVS Health's ( CVS ) Caremark Rx and Cigna's ( CI ) Express Scripts marked up a number of specialty generic drugs at their affiliated pharmacies by hundreds or thousands of percent, the US Federal Trade Commission said Tuesday. The practice allowed the three pharmacy benefit managers...
--KKR Faces DOJ Lawsuit for Allegedly Disregarding Premerger Antitrust Review Process
--KKR Faces DOJ Lawsuit for Allegedly Disregarding Premerger Antitrust Review Process
Jan 14, 2025
11:56 AM EST, 01/14/2025 (MT Newswires) -- Price: 143.04, Change: +1.79, Percent Change: +1.26 ...
Chegg's Recent Share Gains at Odds With Steep Drop in Third-Party Data Trends, Morgan Stanley Says
Chegg's Recent Share Gains at Odds With Steep Drop in Third-Party Data Trends, Morgan Stanley Says
Jan 14, 2025
11:55 AM EST, 01/14/2025 (MT Newswires) -- Chegg's ( CHGG ) recent share price rally from mid-November lows is contradicted by worsening third-party data implying overly optimistic consensus estimates, Morgan Stanley said Tuesday in a note. We think consensus is mis-modeling the potential for growth stabilization and estimates still need to move lower, the firm said, pointing out that its...
Update: Kolibri Global Energy Expects Higher Revenue and Production in 2025
Update: Kolibri Global Energy Expects Higher Revenue and Production in 2025
Jan 14, 2025
11:55 AM EST, 01/14/2025 (MT Newswires) -- (Updates shares.) Kolibri Global Energy ( KGEI ) on Tuesday said it expects its revenue and production from the the Tishomingo field in Oklahoma to rise in 2025. The company's 2025 guidance includes a 38% to 40% increase in average production to a range of 4,500 to 5,100 barrels of oil equivalent per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved